Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Philip C. KENDALL |
Documents disponibles écrits par cet auteur (2)
Faire une suggestion Affiner la recherche
Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement / Cathy CRESWELL in Journal of Child Psychology and Psychiatry, 62-3 (March 2021)
[article]
Titre : Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement Type de document : Texte imprimé et/ou numérique Auteurs : Cathy CRESWELL, Auteur ; Maaike H. NAUTA, Auteur ; Jennifer L. HUDSON, Auteur ; Sonja MARCH, Auteur ; Tessa REARDON, Auteur ; Kristian ARENDT, Auteur ; Denise H. M. BODDEN, Auteur ; Vanessa E. COBHAM, Auteur ; Caroline L. DONOVAN, Auteur ; Brynjar HALLDORSSON, Auteur ; Tina IN-ALBON, Auteur ; Shin-Ichi ISHIKAWA, Auteur ; Daniel Bach JOHNSEN, Auteur ; Maral JOLSTEDT, Auteur ; Rachel DE JONG, Auteur ; Leonie KREUZE, Auteur ; Lynn MOBACH, Auteur ; Ronald M RAPEE, Auteur ; Susan H. SPENCE, Auteur ; Mikael THASTUM, Auteur ; Elisabeth UTENS, Auteur ; Sarah VIGERLAND, Auteur ; Gro Janne WERGELAND, Auteur ; Cecilia A ESSAU, Auteur ; Anne Marie ALBANO, Auteur ; Brian CHU, Auteur ; Muniya KHANNA, Auteur ; Wendy K. SILVERMAN, Auteur ; Philip C. KENDALL, Auteur Article en page(s) : p.255-269 Langues : Anglais (eng) Mots-clés : Anxiety treatment trials Index. décimale : PER Périodiques Résumé : BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. En ligne : http://dx.doi.org/10.1111/jcpp.13283 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443
in Journal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.255-269[article] Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement [Texte imprimé et/ou numérique] / Cathy CRESWELL, Auteur ; Maaike H. NAUTA, Auteur ; Jennifer L. HUDSON, Auteur ; Sonja MARCH, Auteur ; Tessa REARDON, Auteur ; Kristian ARENDT, Auteur ; Denise H. M. BODDEN, Auteur ; Vanessa E. COBHAM, Auteur ; Caroline L. DONOVAN, Auteur ; Brynjar HALLDORSSON, Auteur ; Tina IN-ALBON, Auteur ; Shin-Ichi ISHIKAWA, Auteur ; Daniel Bach JOHNSEN, Auteur ; Maral JOLSTEDT, Auteur ; Rachel DE JONG, Auteur ; Leonie KREUZE, Auteur ; Lynn MOBACH, Auteur ; Ronald M RAPEE, Auteur ; Susan H. SPENCE, Auteur ; Mikael THASTUM, Auteur ; Elisabeth UTENS, Auteur ; Sarah VIGERLAND, Auteur ; Gro Janne WERGELAND, Auteur ; Cecilia A ESSAU, Auteur ; Anne Marie ALBANO, Auteur ; Brian CHU, Auteur ; Muniya KHANNA, Auteur ; Wendy K. SILVERMAN, Auteur ; Philip C. KENDALL, Auteur . - p.255-269.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 62-3 (March 2021) . - p.255-269
Mots-clés : Anxiety treatment trials Index. décimale : PER Périodiques Résumé : BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward. En ligne : http://dx.doi.org/10.1111/jcpp.13283 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=443 Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders / Matti CERVIN in Journal of Child Psychology and Psychiatry, 61-4 (April 2020)
[article]
Titre : Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders Type de document : Texte imprimé et/ou numérique Auteurs : Matti CERVIN, Auteur ; Eric A. STORCH, Auteur ; John PIACENTINI, Auteur ; Boris BIRMAHER, Auteur ; Scott N. COMPTON, Auteur ; Anne Marie ALBANO, Auteur ; Elizabeth GOSCH, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur Article en page(s) : p.492-502 Langues : Anglais (eng) Mots-clés : CBT/cognitive behavior therapy anxiety/anxiety disorders child/adolescent clinical trials pharmacotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Pediatric anxiety disorders are highly prevalent and associated with significant functional disabilities and lifelong morbidity. Cognitive-behavioral therapy (CBT), sertraline, and their combination are effective treatments, but little is known about how these treatments exert their effects. METHODS: Using network intervention analysis (NIA), we analyzed data from the largest randomized controlled treatment trial of pediatric anxiety disorders (Child/Adolescent Anxiety Multimodal Study, NCT00052078, clinicaltrials.gov/ct2/show/NCT00052078) and outlined the causal symptom domain-specific effects of CBT, sertraline, and their combination over the course of the 12-week treatment while taking into account both specificity and overlap between symptom domains. RESULTS: All active treatments produced positive effects with the most pronounced and consistent effects emerging in relation to psychological distress, family interference, and avoidance. Psychological distress was consistently the most and physical symptoms the least central symptom domain in the disorder network. CONCLUSIONS: All active treatments showed beneficial effects when compared to placebo, and NIA identified that these effects were exerted similarly across treatments and primarily through a reduction of psychological distress, family interference, and avoidance. CBT and sertraline may have differential mechanisms of action in relation to psychological distress. Given the lack of causal effects on interference outside family and physical symptoms, interventions tailored to target these domains may aid in the building of more effective treatments. Psychological distress and avoidance should remain key treatment focuses because of their central roles in the disorder network. The findings inform and promote developing more effective interventions. En ligne : http://dx.doi.org/10.1111/jcpp.13124 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=421
in Journal of Child Psychology and Psychiatry > 61-4 (April 2020) . - p.492-502[article] Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders [Texte imprimé et/ou numérique] / Matti CERVIN, Auteur ; Eric A. STORCH, Auteur ; John PIACENTINI, Auteur ; Boris BIRMAHER, Auteur ; Scott N. COMPTON, Auteur ; Anne Marie ALBANO, Auteur ; Elizabeth GOSCH, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur . - p.492-502.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 61-4 (April 2020) . - p.492-502
Mots-clés : CBT/cognitive behavior therapy anxiety/anxiety disorders child/adolescent clinical trials pharmacotherapy Index. décimale : PER Périodiques Résumé : BACKGROUND: Pediatric anxiety disorders are highly prevalent and associated with significant functional disabilities and lifelong morbidity. Cognitive-behavioral therapy (CBT), sertraline, and their combination are effective treatments, but little is known about how these treatments exert their effects. METHODS: Using network intervention analysis (NIA), we analyzed data from the largest randomized controlled treatment trial of pediatric anxiety disorders (Child/Adolescent Anxiety Multimodal Study, NCT00052078, clinicaltrials.gov/ct2/show/NCT00052078) and outlined the causal symptom domain-specific effects of CBT, sertraline, and their combination over the course of the 12-week treatment while taking into account both specificity and overlap between symptom domains. RESULTS: All active treatments produced positive effects with the most pronounced and consistent effects emerging in relation to psychological distress, family interference, and avoidance. Psychological distress was consistently the most and physical symptoms the least central symptom domain in the disorder network. CONCLUSIONS: All active treatments showed beneficial effects when compared to placebo, and NIA identified that these effects were exerted similarly across treatments and primarily through a reduction of psychological distress, family interference, and avoidance. CBT and sertraline may have differential mechanisms of action in relation to psychological distress. Given the lack of causal effects on interference outside family and physical symptoms, interventions tailored to target these domains may aid in the building of more effective treatments. Psychological distress and avoidance should remain key treatment focuses because of their central roles in the disorder network. The findings inform and promote developing more effective interventions. En ligne : http://dx.doi.org/10.1111/jcpp.13124 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=421